Home > Press Room

Contacts:

Onset Therapeutics Mary Theriault Office 401-667-7337 mtheriault@onsettx.com

Granard Pharmaceutical Steve Flood 800-510-3401 sflood@granardrx.com

Onset Therapeutics Announces Agreement with Granard Pharmaceutical for Trade Sales & Marketing

Woonsocket, RI (May 25, 2006) - Onset Therapeutics, a specialty pharmaceutical company that focuses on the development and commercialization of innovative, patent protected topical products for skin and wound related disorders, announced today that they have signed an Agreement with Granard Pharmaceutical Sales and Marketing to provide trade sales & marketing services. Granard will be responsible for contracting with pharmaceutical wholesalers, retail pharmacy chains, and mail order pharmacies and implementing product related promotional programs with this customer segment.

With significant development capabilities that include formulation development through GMP manufacturing, Onset expects to market numerous topical products within the wound care and dermatology markets in 2006. In addition, the company has a full pipeline of products that it intends to launch over the next 3 years. The Agreement is for Granard to represent multiple Onset products in addition to the recently launched Optase^TM for the promotion of wound healing.

"After thoroughly considering all options for bringing our products to the market, including an extensive search of trade sales & marketing companies, we chose Granard because of their solid record of success in launching products into the trade distribution channel. As we launch Optase^TM together, we continue to be impressed with their deep knowledge and relationships in this sector," stated Michael Heffernan, President of Onset Therapeutics.

"We are excited to be working with Onset on the launch of Optase^TM and are looking forward to working with them on many additional products that are in their pipeline," stated Steve Flood, President of Granard. "Onset's strategy to develop products that specifically address some of the limitations inherent in currently available formulations allows Granard to offer highly differentiated products to our trade partners."

About Onset Therapeutics

Onset Therapeutics is a privately held specialty pharmaceutical company focusing on the development and commercialization of novel, patent protected topical products for the treatment of wounds and skin disorders. For more information, please visit the company's website at www.onsettx.com

About Granard Pharmaceutical

Granard Pharmaceutical is a full-service trade sales and marketing company that is dedicated to launching brands & generic products, growing existing product sales, and patent expiration transitions for pharmaceutical manufacturers. The company offers complete turn-key services and provides customized programs to pharmaceutical and bio-tech manufacturers. For more information, please visit the company's website at www.granardrx.com